Researchers identified candidate biomarkers in spinal fluid and blood that showed different patterns among healthy controls, people in a prodromal…
Articles by Steve Bryson, PhD
A score derived from gene activity measured in blood samples can predict a higher risk of developing cognitive impairment and…
People with Parkinson’s disease who experience visual hallucinations have reduced activity in the brain’s cholinergic system, a network of…
Researchers at Texas A&M University have identified a protective brain pathway — one linked to receptors responsive to nicotine but…
Scientists have developed an experimental gene therapy with the potential to treat early-onset Parkinson’s disease associated with…
Vima Therapeutics is gearing up to launch a Phase 2 clinical trial this year to evaluate VIM0423, its potential…
Quitting smoking was linked to a greater risk of Parkinson’s disease compared with continuing to smoke, but it was…
The experimental oral therapy VQ-101 can successfully restore a critical cellular function in people with a genetic form of…
Stanford University researchers developed a simple, portable device that allows Parkinson’s disease patients to monitor their motor symptoms remotely, in…
Herantis Pharma announced that its Phase 1b clinical trial evaluating the safety and preliminary efficacy of HER-096, a potential…